The Maximum Carryover Period of fifteen years constitutes the statutory timeframe during which a Pennsylvania taxpayer may apply unused Research and Development tax credits to offset future qualified state tax liabilities. This provision ensures that innovative firms with prolonged development cycles can preserve the value of their credits even during years of initial fiscal loss or limited tax liability.
Interactive Answer Capsule: 15-Year Carryover Model
Adjust the sliders to simulate how the Pennsylvania R&D tax credit carryover functions over a 20-year timeline.
Adjust sliders to view insight.
Historical Evolution and Legislative Foundation of Article XVII-B
The Pennsylvania Research and Development (R&D) Tax Credit was formally established by Act 7 of 1997, which integrated the program as Article XVII-B of the Tax Reform Code of 1971. The legislative primary objective was to foster an environment conducive to technological advancement and high-wage job creation by incentivizing private sector investment in qualifying research activities within the Commonwealth. This credit was designed as an incremental incentive, rewarding companies that increase their research expenditures year-over-year relative to a historical baseline.
The statutory framework has undergone several significant transformations over the past three decades. Initially, the program featured a “sunset” provision, which meant the credit had an expiration date and required periodic legislative renewal to remain in effect. However, recognizing the necessity for long-term certainty in R&D planning, the Pennsylvania General Assembly enacted Act 85 of 2016, which permanently repealed the sunset date. This legislative permanence is critical because it solidifies the 15-year carryover period as a reliable deferred tax asset for corporate strategic planning.
The program’s fiscal scale has also expanded. For many years, the total annual statewide cap was fixed at $55 million, with a specific set-aside of $11 million for small businesses. More recently, Act 53 of 2022 increased the total annual cap to $60 million, allocating $12 million of that total specifically for qualified small businesses. This cap is fixed through June 30, 2025, ensuring a predictable pool of resources for the immediate future.
Statutory Definition of the Fifteen-Year Carryover Period
The legal mechanics of the carryover are codified in Section 1704-B of the Tax Reform Code. The statute provides a clear hierarchy for how the credit must be handled if it cannot be fully utilized in the year of approval.
The Rolling Carryforward Mechanism
According to Section 1704-B(a), if a taxpayer cannot use the entire amount of the research and development tax credit for the first taxable year in which they were entitled to claim it, the excess amount may be carried over to succeeding taxable years. The “first taxable year” for which the taxpayer is entitled to claim the credit marks the beginning of the 15-year clock.
The statute dictates a reducing-balance method for the carryover: each time the credit is carried forward, it is reduced by the amount used as a credit during the immediately preceding taxable year. This ensures a sequential utilization where older credits (first-in, first-out) are generally applied first to minimize the risk of expiration. The credit may be carried over and applied for “no more than fifteen taxable years” following the initial entitlement year. Once this 15-year window closes, any remaining unused credit amount expires and is legally extinguished.
Prohibitions on Carryback and Refundability
A fundamental aspect of the Pennsylvania R&D credit, distinguishing it from certain federal provisions, is the absolute prohibition on carrybacks and refunds. A taxpayer is not permitted to apply the credit to prior years to obtain a refund of taxes already paid. This forward-only nature places the entire utility of the credit on the 15-year carryover period or the secondary market for credit sales.
Qualified Tax Liabilities
The carryover applies to specific “qualified tax liabilities” defined under the Tax Reform Code. These include:
- Corporate Net Income Tax (CNIT) under Article IV.
- Personal Income Tax (PIT) under Article III, which is particularly relevant for shareholders and partners of pass-through entities.
- Historically, the Capital Stock and Franchise Tax (CSFT), though this tax was phased out at the end of 2015.
| Feature of Pennsylvania R&D Carryover | Statutory Requirement and Legal Context |
|---|---|
| Carryforward Duration | 15 succeeding taxable years. |
| Carryback Permission | Strictly prohibited; no prior year offsets. |
| Refundability | Non-refundable; credit only offsets actual liability. |
| Sequential Use | Must be reduced by prior year utilization. |
| Expiration | Extinguished after 15 years if not used or sold. |
| Application Method | Non-automatic; requires annual DOR approval. |
Pennsylvania Department of Revenue: Administrative Guidance and Filing Requirements
The Pennsylvania Department of Revenue (DOR) maintains strict administrative oversight to ensure that credits being carried forward are legitimate and supported by qualifying activity. The transition of the carryover balance from year to year requires meticulous record-keeping and compliance with specific guidance found in the DOR’s publications and online filing systems.
myPATH and the Application Lifecycle
All applications for the R&D credit must be submitted through myPATH, the Department’s online filing system. This digital infrastructure facilitates the tracking of the 15-year carryover by maintaining a historical record of a taxpayer’s approved credits and subsequent utilization.
The application window is highly specific:
- August 1: The application window opens.
- December 1: The deadline for submission.
- May 1: The date by which the DOR notifies the taxpayer of the approved credit amount for the year.
This timeline is based on expenses incurred in the taxable year that ended in the prior calendar year. For example, a company applying by December 1, 2024, is seeking a credit for qualified research expenses (QREs) incurred during the 2023 tax year.
Mandatory Compliance and Tax Clearance
A taxpayer cannot carry forward or receive a new credit if they are not in full “tax clearance” with the Commonwealth. The DOR performs a compliance check to ensure all state tax reports have been filed and all outstanding liabilities have been paid. This requirement extends to any owner of 20% or more of the business. If an entity is deemed non-compliant, its application for a credit—and by extension, the initiation of a 15-year carryover period—will be denied.
Form REV-545 and Substantiation
The core document for establishing the carryover is Form REV-545 (Pennsylvania Research and Development Tax Credit Application). This form requires a breakdown of QREs and the calculation of the “base amount”. The DOR follows the federal definition of “qualified research” under Section 41 of the Internal Revenue Code, which includes the well-known four-part test: the research must be technological in nature, have a permitted purpose, seek to eliminate technical uncertainty, and involve a process of experimentation.
For the purpose of the 15-year carryover, taxpayers must maintain detailed project narratives and payroll records to defend the credit in the event of an audit, which can occur years after the initial research was conducted. The DOR mandates that audit-ready documentation be retained for at least five years post-application.
The 15-Year Horizon for Small Businesses vs. Large Businesses
The Pennsylvania R&D tax credit distinguishes between small and large businesses, primarily through the credit rate and the specific set-aside of the annual cap. This distinction heavily influences how different types of companies utilize the 15-year carryover.
Qualified Small Business (QSB) Advantages
A “small business” is defined as a for-profit corporation, LLC, partnership, or proprietorship with a net book value of assets totaling less than $5 million at the beginning or end of the taxable year for which the expenses were incurred.
Small businesses receive a significant incentive: a 20% credit rate on excess QREs, which is double the 10% rate provided to large businesses. Furthermore, the $12 million set-aside for small businesses often results in a higher proration rate compared to the general pool. In 2024, small businesses received 100% of their tentative requests, whereas large businesses were significantly prorated due to oversubscription of the general $48 million pool.
The Lifecycle of a Startup and the Carryover
For many small technology startups, the 15-year carryover is a critical bridge. These companies typically experience high R&D spending in their early years but do not generate taxable income for several years. The ability to bank these credits at a 20% rate and carry them forward for 15 years allows these startups to “store” tax savings that will become immensely valuable once they reach commercial viability and begin generating a Corporate Net Income Tax liability.
The Sale and Assignment Program: Monetizing the Carryover
If a company determines that it will not be able to utilize its credits internally within the 15-year window—or if it simply needs immediate liquidity—Pennsylvania offers a unique “Assignment Program”. This program allows the original recipient (the seller) to assign or sell their unused credits to another Pennsylvania taxpayer (the buyer).
Transfer Guidelines for Sellers
Under current law, credits awarded in 2009 or later can be sold immediately once approved. To initiate a sale, the seller must apply to the Department of Community and Economic Development (DCED). The seller must demonstrate that they have not already used the credit and that it remains within its 15-year “lifetime”.
A critical protection for the Commonwealth is the requirement that the seller must be in full tax compliance before the sale is approved. If the DOR later determines the seller was not entitled to the credit, the seller—not the buyer—is responsible for paying back the taxes, along with interest and penalties.
Limitations for Buyers: The 75% Offset and Zero Carryover
While the seller enjoys a 15-year carryover, the buyer of an R&D tax credit is subject to much stricter utilization rules.
- Immediate Utilization: The buyer must claim the credit in the taxable year in which the purchase or assignment is made.
- 75% Utilization Cap: A purchaser cannot use the credit to offset more than 75% of their qualified tax liability for that specific year.
- No Carryover or Carryback: A buyer is strictly prohibited from carrying forward any unused portion of the purchased credit to future years or carrying it back to prior years.
- No Resale: The credit can only be assigned once. The buyer cannot resell the credit to another party.
These restrictions significantly influence the market value of the credits. Because the buyer must use the credit immediately and can only offset 75% of their tax, they typically purchase the credits at a discount. Historically, these credits have sold for approximately 92.9% of their face value, providing a high level of liquidity for the innovative firm that originally earned them.
Pass-Through Entity Dynamics: S-Corporations, Partnerships, and LLCs
Pennsylvania law provides specific mechanisms for pass-through entities (PTEs) to utilize R&D credits, which introduces further complexity into the 15-year carryover analysis.
Distributing Credits to Owners
Effective for awards made after December 15, 2006, PTEs—including S-corporations, limited liability companies, and partnerships—can transfer or “pass through” their approved R&D credits to their shareholders, members, or partners. This is done in proportion to the owners’ distributive share of the entity’s income.
The DOR guidance for PTEs, specifically regarding Schedule OC, states that the entity must first apply the credit to its own corporate tax liability (if any) before passing the remainder to the owners. If an entity elects to pass through the credit, that election is irrevocable.
Carryover Restrictions for Individual Owners
Crucially, the 15-year carryover period does not transfer to individual owners in the same way it applies to the original entity. According to the Department’s guidance, an owner who receives a passed-through R&D credit must immediately claim the credit in the taxable year in which the transfer is made.
The individual owner:
- May not carry forward any unused portion of the passed-through credit.
- May not carry back the credit.
- May not obtain a refund.
- May not sell, assign, or pass through the credit again.
This creates a high-stakes planning environment for PTEs. If a partnership passes through $100,000 in credits to a partner, but that partner only has $20,000 in Personal Income Tax liability, the remaining $80,000 is lost forever. Therefore, the Department of Revenue advises that entities should not pass through more than the owners can use in any single year. Instead, the PTE should retain the excess credit and carry it forward at the entity level, utilizing its own 15-year carryover window to pass through smaller increments in subsequent years.
| Entity Structure | Carryover Logic and Restrictions |
|---|---|
| C-Corporation | Retains 15-year carryover; can offset 100% of CNIT. |
| PTE (Entity Level) | Retains 15-year carryover; can pass through incrementally. |
| Individual Owner | No carryover; must use immediately in the year of pass-through. |
| Credit Purchaser | No carryover; must use immediately and capped at 75% offset. |
Comparative Analysis: Pennsylvania vs. Federal R&D Provisions
Understanding the value of the 15-year Pennsylvania carryover requires a comparison with the federal Research Credit under IRC Section 41. While Pennsylvania aligns with the federal definition of qualifying research, its administrative and carryover rules differ significantly.
Divergent Carryover and Carryback Rules
The federal research credit allows for a 20-year carryforward and a 1-year carryback. Pennsylvania’s 15-year carryforward is shorter, and its absolute ban on carrybacks creates a more rigid utilization schedule. This necessitates a more active management of the tax asset at the state level.
Incremental Calculation Methods
Both credits use an incremental approach, but Pennsylvania uses a modified base calculation. The Pennsylvania “base amount” is the greater of:
- 50% of the current year’s Pennsylvania QREs.
- The average of the prior four years of Pennsylvania QREs.
This “50% floor” is unique to Pennsylvania and acts as a built-in proration that limits the total credit amount a company can earn in a high-growth year, which in turn preserves the state’s tax base.
Transferability: The Pennsylvania Advantage
The most significant difference is transferability. Federal R&D credits generally cannot be sold to third parties for cash. Pennsylvania’s Sale and Assignment program effectively creates a market for these credits, allowing companies that are “in a loss position” to realize the value of their research investments immediately rather than waiting for future profitability within the 15-year carryover window.
Quantitative Example: The 15-Year Lifecycle of “InnovatePA LLC”
To illustrate the interaction between the law, revenue office guidance, and the carryover mechanism, consider the following hypothetical scenario for InnovatePA LLC, a qualified small business specializing in biomedical manufacturing.
Step 1: Initial Credit Calculation (Year 1)
In its first year of filing, InnovatePA LLC incurs significant expenses to develop a new diagnostic formulation.
- 2023 PA QREs: $1,000,000
- Base Amount: $500,000 (Greater of 50% current year or 4-year average)
- Excess QREs: $500,000
- Credit Rate: 20% (Small Business)
- Tentative Credit: $100,000
- Approval: By May 1, 2025, the DOR notifies the company that they have been awarded the full $100,000.
Step 2: Internal Utilization and Carryover (Years 1-3)
The company is an LLC and elects to use the credit against its own limited tax liabilities first.
- Year 1 (2025): Tax liability is $10,000. The company uses $10,000 and carries forward $90,000.
- Year 2 (2026): Tax liability is $15,000. The company uses $15,000 and carries forward $75,000.
- Year 3 (2027): The company suffers a major loss and has $0 tax liability. The full $75,000 is carried forward.
Step 3: Pass-Through Strategy (Year 4)
In 2028, the company remains in a loss position but its sole member (John) has personal income tax liability from other sources.
- John’s PIT Liability: $30,000.
- Strategy: The LLC irrevocably elects to pass through exactly $30,000 of the credit to John.
- Result: John uses the $30,000 to offset his PIT. The LLC retains $45,000 in its entity-level carryover pool.
- Caution: If the LLC had passed through all $75,000, John would have used $30,000 and the remaining $45,000 would have been lost because individual owners cannot carry forward passed-through credits.
Step 4: Monetization through Sale (Year 5)
In 2029, the company needs working capital for a new laboratory.
- Remaining Credit: $45,000.
- Action: The company applies to DCED to sell the remaining $45,000.
- The Buyer: A large Pennsylvania manufacturing firm with a $1,000,000 tax liability.
- The Transaction: The buyer pays $41,805 (92.9% of face value) to InnovatePA LLC.
- The Outcome for Buyer: The buyer uses the $45,000 to offset its tax liability (the $45,000 is well below the 75% offset cap of $750,000).
The Impact of Oversubscription and Proration
The $60 million annual cap is the primary constraint on the 15-year carryover’s initial value. Because all timely applications are reviewed simultaneously, the Department of Revenue must often prorate awards if the total requests exceed the available funds.
Historically, the “small business” set-aside ($12 million) has been less oversubscribed than the general pool ($48 million). This means that a large corporation might qualify for a $1,000,000 credit but only receive an award of $411,000 (assuming a 41.1% proration). This proration makes the 15-year carryover even more vital; because companies receive less credit than anticipated, they must carefully plan the utilization of these smaller “buckets” of credit over a longer period to ensure they eventually capture the full intended benefit of their research investments.
| Proration Context (2024 Estimates) | Tentative Request | Proration Rate | Final Award (Initial Carryover) |
|---|---|---|---|
| Small Business Pool ($12M) | $7.2 Million | 100% | Full Amount Approved. |
| General Pool ($48M) | ~$116 Million | ~41.1% | Significant Reduction. |
Audit Defense and Long-Term Record Retention
The 15-year carryover creates a long “tail” of potential audit risk. The Department of Revenue has the authority to review the validity of research expenses for years after the credit was initially approved, especially when those credits are finally used to offset tax or are put up for sale.
Five-Year vs. Fifteen-Year Retention
The DOR requires record retention for five years post-application. However, because the credit can be carried forward for 15 years, a “gap” exists where a credit used in Year 12 might be questioned based on documentation that was only legally required to be kept through Year 5. Domain experts generally recommend that Pennsylvania R&D tax credit recipients maintain all technical and financial substantiation for the entire duration of the 15-year carryover period, plus the statute of limitations for the year in which the credit is finally fully utilized.
The Role of CPA Audits
To streamline the approval and verification process, the DOR increasingly allows for CPA-certified audits of the QRE calculations. While not mandatory for all applicants, a voluntary CPA audit at the time of initial application can significantly reduce the technical risk during the subsequent 15-year carryover period, as it provides a robust baseline for the Department’s initial review.
Appeals Process (Act 25 of 2021)
Act 25 of 2021 introduced a formal appeals process for taxpayers, brokers, and the Department concerning the administration of tax credits. This is a critical development for carryover management. If the Department decides to reduce or eliminate a carryover balance during an audit in Year 10, the taxpayer now has a codified legal right to appeal that determination through the Board of Appeals.
Strategic Implications of the Carryover for Corporate Planning
The fifteen-year carryover is not merely a technical rule but a strategic asset that influences corporate behavior and economic development within Pennsylvania.
Location Decisions and Capital Investment
The permanence of the credit (Act 85) combined with the long carryover makes Pennsylvania an attractive location for capital-intensive research industries like biotechnology, semiconductor manufacturing, and aerospace. Companies in these sectors can invest hundreds of millions in research today, knowing that the resulting tax credits will be available to offset their future tax liabilities for over a decade.
Mergers and Acquisitions (M&A)
In M&A transactions involving Pennsylvania technology firms, the R&D credit carryover is often a significant line item in the valuation. A target company with a $5,000,000 carryover balance is a more valuable acquisition for a profitable buyer that can use those credits to immediately reduce its own Pennsylvania tax burden (subject to the 75% offset rule and the requirement that the credits are sold or assigned properly).
Cash Flow Management
The combination of the 15-year carryover and the Assignment Program provides Pennsylvania companies with a unique “tax-based treasury” function. In years of low interest rates, a company might choose to carry its credits forward to offset future 9.99% Corporate Net Income Tax. In years where cash is scarce or interest rates for debt are high, the company can pivot and sell its credits to generate immediate working capital at a small discount.
Final Thoughts and Recommended Best Practices
The Maximum Carryover Period of 15 years for the Pennsylvania R&D tax credit serves as a vital safeguard for the Commonwealth’s innovative industrial base. By providing an extended window for utilization, the law acknowledges the long-term nature of scientific discovery and the cyclical nature of technology markets.
To maximize the value of this 15-year asset, taxpayers should adopt the following strategic posture:
- Maintain Continuous Compliance: Ensure that the entity and all major owners remain in state tax clearance, as any lapse can freeze the ability to apply for new credits or utilize existing carryover balances.
- Strategic Pass-Through Planning: For partnerships and S-corps, carefully calculate owner-level tax liability before passing through credits. Any amount passed through that cannot be used immediately is permanently lost.
- Active Asset Monitoring: Treat the R&D carryover as a financial asset with a “maturity date” of 15 years. Companies should regularly evaluate whether internal utilization or a market sale (Assignment) provides the highest net present value for the credit.
- Exhaustive Documentation: Maintain research project records for the full 15-year lifecycle. The ability to carry over the credit is contingent upon the ability to defend the original research’s eligibility years after the fact.
The Pennsylvania R&D tax credit, through its Article XVII-B framework, remains one of the most flexible and durable innovation incentives in the United States. By combining a high credit rate for small businesses with a robust market for credit transfers and a long-term carryover period, the Commonwealth has created a powerful mechanism for sustained economic and technological leadership.
Who We Are:
Swanson Reed is one of the largest Specialist R&D Tax Credit advisory firm in the United States. With offices nationwide, we are one of the only firms globally to exclusively provide R&D Tax Credit consulting services to our clients. We have been exclusively providing R&D Tax Credit claim preparation and audit compliance solutions for over 30 years. Swanson Reed hosts daily free webinars and provides free IRS CE and CPE credits for CPAs.
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/





